Patent details
EP3811941
Title:
PHARMACEUTICAL COMPOSITION CONTAINING ILAPRAZOLE AND SALT THEREOF AND PREPARATION METHOD THEREFOR
Basic Information
- Publication number:
- EP3811941
- PCT Application Number:
- CN2018111611
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP189236797
- PCT Publication Number:
- WO2019242181
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITION CONTAINING ILAPRAZOLE AND SALT THEREOF AND PREPARATION METHOD THEREFOR
- French Title of Invention:
- COMPOSITION PHARMACEUTIQUE CONTENANT DE L'ILAPRAZOLE ET UN SEL DE CELUI-CI ET SON PROCÉDÉ DE PRÉPARATION
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT ILAPRAZOL UND SALZ DAVON UND VERFAHREN ZU IHRER HERSTELLUNG
- SPC Number:
-
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 21/12/2023
- Link to UPP Register:
-
European Patent Register
- Unitary Effect Request Withdrawal Date:
-
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 08/01/2024
- Unitary Effect Rejection Decision Date:
-
- Unitary Effect Date:
- 29/11/2023
- Unitary Effect Registration Date:
- 08/01/2024
- Unitary Effect Re-establishment of rights Filing Date:
-
- Unitary Effect Re-establishment of rights EPO Decision :
-
- Unitary Effect Re-establishment of rights EPO Decision Date:
-
- Explanatory Text UE:
-
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
-
Dates
- Filing date:
- 24/10/2018
- Grant date:
- 29/11/2023
- EP Publication Date:
- 28/04/2021
- PCT Publication Date:
- 26/12/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 29/11/2023
- EP B1 Publication Date:
- 29/11/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 24/10/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 22/11/2023
-
-
- Name:
- Livzon Pharmaceutical Group Co., Ltd
- Address:
- 38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong 519090, China (CN)
Inventor
1
- Name:
- CHEN, Jialu
- Address:
- China (CN)
2
- Name:
- LU, Wenqi
- Address:
- China (CN)
3
- Name:
- LI, Jing
- Address:
- China (CN)
4
- Name:
- WANG, Tao
- Address:
- China (CN)
5
- Name:
- ZHANG, Xiangna
- Address:
- China (CN)
6
- Name:
- HOU, Xuemei
- Address:
- China (CN)
7
- Name:
- ZHANG, Yurong
- Address:
- China (CN)
8
- Name:
- CHEN, Hongdan
- Address:
- China (CN)
9
- Name:
- KONG, Xiangsheng
- Address:
- China (CN)
10
- Name:
- TU, Zengqing
- Address:
- China (CN)
11
- Name:
- WU, Xiaohong
- Address:
- China (CN)
12
- Name:
- CHENG, Caihua
- Address:
- China (CN)
Priority
- Priority Number:
- 201810652046
- Priority Date:
- 22/06/2018
- Priority Country:
- China (CN)
Classification
- IPC classification:
-
A61K 31/4439;
A61K 9/19;
A61K 47/02;
A61P 1/04;
A61K 9/00;
A61K 47/26;
A61K 47/18;
Publication
European Patent Bulletin
1
- Issue number:
- 202348
- Publication date:
- 29/11/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202404
- Publication date:
- 24/01/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202406
- Publication date:
- 07/02/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |